Lobin D, Kazatchkine M. Immunoglobuline intraveineuse et suppression anti-idiotype de l'autoimmunité. Rev Med Int 1992; 13: 162-5.
Thorntan CA, Ballow M. Lofety in intravenous immunoglobulin. Arch Neurol 1993; 50: 135-6.
Voltz R, Van Rozen F, Yousry T, et al. Reversible encephalopathy with cerebral vasnspasm in a GBS patient treated with iv immunoglobulin. Neurology 1996; 46: 250-1.
Schiff RI, Rudd C, Alteration in the half time and clearance of IgG during therapy with intravenous gammaglobulin in 16 patients with severe primary humoral immunodeficiency. J Clin Immunol 1986; 6: 256-64.
Arsura EL, Bick A, Brunnel NG. High-dose intravenous immunoglobulin in the management of myasthenia gravis. Arch Intermed 1986; 146: 1365-8.
Gadjos Ph, Ghastang Cl, Clair B, et al. First interim analysis of a randomized clinical trial comparing plasma exchange and intravenous immunoglobulin on myasthenia gravis. Neuromusc Dis 1996; 4 : S51.
Van Der Meche FGA, Schmitz P, and the Dutch Guillain-Barre study group. A randomized trial comparing intravenous immunoglobulin and plasma exchange in Guillain-Barie Syndrome. N Engl J Med 1992; 326: 1123-9
The Dutch Guiliain-Barré study group. Treatment of Guillain-Barré syndrome with high dose immunoglobulins combined with methylprednisolone. A pilot study. Ann Neurol 1994; 35: 749-52.
Hahn AF, Bolton CF, Zochodne, et al. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy. A double blind, placebo-controlled croos-over study. Brain 1996; 119: 1067-77.
Van Doom PA, Vermeulen M, Brand A, et al. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement. Arch Neurol 1991; 48: 217-20.
Dyck PJ, William JL, Kay MK. A plasma exchange versus immunoglobulin infusion. Trial chronic inflammatory demyelinaling polyradiculopathy. Ann Neurol 1994; 36: 838-45.
Choudary PP, Hughes RAC. Long term treatment of chronic inflammatory demyelinating polyradiculopathy with plasma exchange or intravenous immunoglobulin. Q J Med 1995; 88:493-502.
Dalakas MC, Quarles RH, Farrer RG. A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammapathy. Ann Neurol 1996; 40: 792-5.
Pouget J, Azulay J-Ph, Boucraut J. Les neuropathies motrices multifocates avec blocs de conduction persistants : une forme de neuropathie démyélinisante inflammatoire. Rev Neurol 1996; 152: 370-4.
Feldman EL, Bromberg MB, Albers JW. Immunosuppressive treatment in multifocal motor neuropathy. Ann Neural 1991; 30: 397-401.
Nobile-Orazio E, Meuci N, Barbieri S, et al. High dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993; 43: 537-44.
Azulay J-Ph, Rihet P, Pouget J. Long term follow-up of multifocal motor neuropathy. Report of 18 patients Neurology 1995: 45 (Suppl 4):A416-7.
Cherin P, Herson S. Nouvelles thérapeutiques aans ies polymyosites et dermatomyosites. Echanges plasmatiques et immunoglobulines intraveineuses. Ann Med Intern 1993; 144: 521-5.
